El Dr Manel Esteller, de l’Institut d’Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL), ha rebut una ajuda Merck Serono d’Investigaci\u00f3 2012 en l’\u00e0rea de recerca en bases moleculars de les malalties rares i les seves implicacions cl\u00edniques pel projecte “Caracteritzaci\u00f3 epigen\u00e8tica de la S\u00edndrome de Sotos. Avaluaci\u00f3 de l’\u00fas de tractaments farmacol\u00f2gics adre\u00e7ats a potenciar l’expressi\u00f3 de microRNAs”.<\/p>\n
Despr\u00e9s de 20 anys, els ajuts Merck Serono d’Investigaci\u00f3 continuen sent un ferm comprom\u00eds amb la investigaci\u00f3 biom\u00e8dica a Espanya. Amb una inversi\u00f3 de 140.000 \u20ac, s’han premiat treballs en set \u00e0rees de recerca com al\u00b7lergologia, cardiometabolisme, endocrinologia, malalties rares, esclerosi m\u00faltiple, fertilitat i oncologia.<\/p>\n
La Fundaci\u00f3n Salud 2000 ha fet lliurament dels Ajuts Merck Serono d’Investigaci\u00f3 2012, que han estat rebudes pels investigadors guardonats de mans de Carmen Vela, Secret\u00e0ria d’Estat d’Investigaci\u00f3, Desenvolupament i Innovaci\u00f3; Bel\u00e9n Crespo, directora de l’Ag\u00e8ncia Espanyola de Medicaments i Productes Sanitaris, i Mar\u00eda Gasset, vicepresidenta Adjunta d’\u00e0rees cient\u00edfico-t\u00e8cniques del Consell Superior d’Investigacions Cient\u00edfiques (CSIC), i ha estat celebrat a la seu central del CSIC.<\/p>\n
“Els Ajuts Merck Serono s\u00f3n una evident mostra del nostre comprom\u00eds amb la recerca i el desenvolupament de projectes innovadors. Una activitat, que desenvolupem des dels nostres inicis, per\u00f2 que cobra especial valor en temps com els actuals, en qu\u00e8 el suport i el finan\u00e7ament de la recerca travessa un moment delicat”, ha afirmat Carmen Gonz\u00e1lez Madrid, presidenta Executiva de la Fundaci\u00f3n Salud 2000, que tamb\u00e9 va participar en l’acte. “El nostre principal objectiu \u00e9s seguir donant suport a la innovaci\u00f3 biom\u00e8dica a Espanya i contribuir aix\u00ed a la millora en la qualitat de vida dels pacients que pateixen malalties tan prevalents com el c\u00e0ncer o tan incapacitants com l’esclerosi m\u00faltiple, entre d’altres”, conclou.<\/p>\n
Els Ajuts Merck Serono d’Investigaci\u00f3 celebren el seu XX aniversari, havent-se convertit en un referent en recerca i desenvolupament. “El nostre objectiu \u00e9s continuar al costat dels professionals sanitaris, apostant per projectes de recerca de gran qualitat que esdevinguin importants aven\u00e7os m\u00e8dics”, ha assenyalat Rogelio Ambrosio, President del Patronat de la Fundaci\u00f3n Salud 2000. “A m\u00e9s, cada dia es fa m\u00e9s ferma la necessitat de col\u00b7laboraci\u00f3 p\u00fablico-privada per avan\u00e7ar en el desenvolupament de la recerca, ja que la finalitat \u00faltima de l’avan\u00e7 de la ci\u00e8ncia \u00e9s desenvolupar tractaments que contribueixin a millorar la salut dels pacients, i com conseq\u00fc\u00e8ncia de tota la societat”.<\/p>\n
Convocades anualment des de 1991, els ajuts Merck Serono d’Investigaci\u00f3 tenen com a objectiu finan\u00e7ar projectes de recerca in\u00e8dits, presentats per investigadors espanyols i que es puguin desenvolupar a Espanya. Cada projecte seleccionat rebr\u00e0 un ajut de 20.000 euros.<\/p>\n","protected":false},"excerpt":{"rendered":"
El Dr Manel Esteller, de l’Institut d’Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL), ha rebut una ajuda Merck Serono d’Investigaci\u00f3 2012 en l’\u00e0rea de recerca en bases moleculars de les malalties rares i les seves implicacions cl\u00edniques pel projecte “Caracteritzaci\u00f3 epigen\u00e8tica de la S\u00edndrome de Sotos. Avaluaci\u00f3 de l’\u00fas de tractaments farmacol\u00f2gics adre\u00e7ats a potenciar l’expressi\u00f3 de […]<\/p>\n","protected":false},"author":6,"featured_media":21621,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[376],"tags":[],"publishpress_future_action":{"enabled":false,"date":"2024-05-11 11:53:34","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/9493"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=9493"}],"version-history":[{"count":2,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/9493\/revisions"}],"predecessor-version":[{"id":21622,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/9493\/revisions\/21622"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/21621"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=9493"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=9493"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=9493"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}